The value of biosimilars: from strategy to action
On June 10, 2022, the fourth edition of our National Conference on Biosimilars entitled "The value of biosimilars: from strategy to action" will be held.
Call for papers
Proposal for action for the use of biosimilars in the new SNS: the vision of IBD
Manuel Barreiro de Acosta
Univ. Santiago Clinical Hospital
President of GETECCU
How to align the acquisition of biosimilar medicines with pharmaceutical policy? Perspective of Scientific Societies
Javier García Alegría
FACME Vice President
Informative and training campaigns for patients and society
Ana Sánchez
OCU Health Manager
